Senior Manager, Corporate Development & Strategic Analytics

Who we are

REGENXBIO is an exceptional place to work. You'll have the opportunity to collaborate with some of the best and the brightest people, touch amazing science, and be part of extraordinary plans. Our core values:
Trust, Accountability, Perseverance, and Innovation drive everything we do. We aim to bring these values to life every day with all that we do, and we believe that what we do matters - to patients, to their families, and to their communities.

As Senior Manager, Corporate Development & Strategic Analytics, you will play a critical role in supporting business development, licensing, M&A, and competitive intelligence activities through strategic modeling and financial analysis. You’ll contribute to the development of long-range planning models, valuation of internal and external opportunities, and creation of decision-driving materials for executive leadership. Additionally, you’ll be supporting deal execution, cross-functional due diligence, and alliance management.

In partnership with the Senior Director, this position ensures a consistent and strategic approach to evaluating opportunities and advancing corporate growth initiatives.

• Assist and maintain comprehensive three statement model detailing long range plan (LRP) and SOTP analysis identifying key drivers of value across product portfolio, future programs and sublicenses
• Assist with strategic financial modeling exercises (both bona fide and theoretical), ranging in complexity from bespoke program NPVs to three statement merger models; insights inform and underpin strategic decision making
• At an organizational level, employ and maintain consistent valuation approaches including general discounting conventions and risk adjustment
• Create modeling tools to drive efficiency for different functions
• Support recurring / ad-hoc competitive intelligence analyses and data harvesting
• Support execution of transactions to build REGENXBIO’s portfolio and technologies
• Support identification and prioritization of new business opportunities as well partnering efforts with respect to REGENXBIO existing assets
• Support and conduct cross functional due diligence in coordination with other functions including R&D, clinical, manufacturing, and commercial
• Support generation of analyses and executive ready materials in connection with all opportunities setting forth strategic rationale therefor
• Assist and perform post deal integration and certain alliance management activities
• It is imperative that REGENXBIO employees embody our core values by working collaboratively, building strong relationships and using clear communication to meet shared objectives.

• Bachelor’s Degree with a concentration in finance or scientific discipline required;
  Master’s Degree (MBA, or similar) preferred.
• +5 years investment banking, private equity or equity research experience at bulge bracket institution or biotechnology corporate development required.
• Advanced, extensive financial, valuation and strategic modeling experience spanning transactions ranging in complexity from licensing to M&A.
• Experience or general familiarity with biotechnology industry sourcing, evaluation, coordination and execution of strategic transactions.
• General understanding of the underlying science, clinical development, as well as the business components of product development.
• Skill in prioritizing and triaging obligations; ability to independently manage a wide range of projects and relationships
• Detail-oriented, ability to handle pressure and meet deadlines.
• Outstanding organizational, analytical, interpersonal and communication skills
• Ability to deliver executive-ready presentation with minimal oversight and guidance
• Adaptability, flexibility, and willingness to work in a changing environment
• A collaborative nature with the knowledge and understanding of the role and importance of working cross-functionally
• Self-starter, highly motivated, results-driven individual; ability to creatively solve problems
• Expert facility and understanding of the Microsoft Office, Capital IQ, Evaluate Pharma, Citeline, VDR software / platforms

By joining…